May 2015 FDA Recall Fentanyl Citrate by West-ward Pharmaceutical Corp. (D-1139-2015 - Failed Impurities/Degradation Specifications; 12 month stability testing (Expansion of RES #70548).)

This Class III drug recall was voluntarily initiated by West-ward Pharmaceutical Corp. on May 13, 2015 for the product Fentanyl Citrate. The FDA reported the reason for recall as failed impurities/degradation specifications; 12 month stability testing (expansion of res #70548).. The product was distributed Nationwide and the recall is currently terminated.

Recall Number: D-1139-2015

Reason for Recall
Failed Impurities/Degradation Specifications; 12 month stability testing (Expansion of RES #70548).
Initiated
05-13-2015
Reported
06-24-2015
Quantity
14,649 Cartons

Recall Profile & Regulatory Data

Class III - is a situation in which use of, or exposure to, a violative product is not likely to cause adverse health consequences.
West-Ward Pharmaceutical Corp.
Fentanyl Citrate Inj., USP, CII, 250 mcg/5 mL (50 mcg/mL) (0.05 mg/mL), Rx Only, For IV or IM Use Preservative Free, 25 X 5 mL Single Dose Vials per Carton, Manufactured by: West-Ward, Eatontown, NJ 07724 USA, NDC 0641-6028-25.

Batch or Lot Expiration Information

Lot# : 043410, Exp 04/2015; 053391, Exp 05/2015; 073340, Exp 07/2015; 083330, 083333, 083335, Exp 08/2015; 093319, 093321, 093323, Exp 09/2015; 103316, 103318, Exp 10/2015